Table 1.
Clinical feature | All cases | Baseline NLR | P value | |
---|---|---|---|---|
<2.21 | ≧2.21 | |||
No.(%) | No.(%) | |||
Patient number | 124 | 75 (60.5) | 49 (39.5) | |
Age (means ± SD) | 49.8 ± 12.9 | 47.0 ± 14.8 | 0.2694 | |
Sex | 0.2689 | |||
Male | 55 | 30 (54.5) | 25 (45.5) | |
Female | 69 | 45 (65.2) | 24 (34.8) | |
NF2 | 0.1104 | |||
+ | 11 | 4 (36.4) | 7 (63.6) | |
- | 113 | 71 (62.8) | 49 (37.2) | |
Tumor status | >0.9999 | |||
primary | 109 | 66 (60.6) | 43 (39.4) | |
recurrent | 15 | 9 (60.0) | 6 (40.0) | |
Tumor origin | 0.2212 | |||
CN 8 | 91 | 52 (57.1) | 39 (42.8) | |
non CN 8 | 33 | 23 (69.7) | 10 (30.3) | |
Neurological symptoms | 0.5629 | |||
+ | 110 | 65 (59.1) | 45 (40.9) | |
- | 14 | 10 (71.4) | 4 (28.6) | |
Tumor size (mm) | 24.8 ± 13.0 | 29.1 ± 12.0 | 0.0713 | |
Brain compression | 0.3416 | |||
+ | 79 | 45 (57.0) | 34 (43.0) | |
- | 45 | 30 (66.7) | 15 (33.3) | |
Tumor cyst | 0.3610 | |||
+ | 59 | 33 (55.9) | 26 (44.1) | |
- | 65 | 42 (64.6) | 23 (35.4) | |
Removal rate | 0.0228 | |||
GTR | 46 | 34 (73.9) | 12 (26.1) | |
non-GTR | 78 | 41 (52.6) | 37 (47.4) |
NLR, neutrophil-to-lymphocyte ratio; SD, standard deviation; NF2, neurofibromatosis type 2; CN, cranial nerve; GTR, gross total resection.
Factors which made statistically significant differences are shown in bold.